Jessica Lynn has an educational background in writing and marketing. She firmly believes in the power of writing in amplifying voices, and looks forward to doing so for the rare disease community.

    FDA Clears Global Phase 3 Study of Lisaftoclax for Previously Treated CLL or SLL
    Source: https://pixabay.com/en/white-blood-cell-cell-blood-cell-543471/

    FDA Clears Global Phase 3 Study of Lisaftoclax for Previously Treated CLL or SLL

      In Jordyn Sava's reporting from Targeted Oncology, readers learn that the U.S. Food and Drug Administration (FDA) granted clearance to a global Phase 3 study. This means that the…

    Continue Reading FDA Clears Global Phase 3 Study of Lisaftoclax for Previously Treated CLL or SLL
    China Expands Medical Insurance Coverage to Improve Access and Affordability for Rare Disease Drugs
    Free-Photos / Pixabay

    China Expands Medical Insurance Coverage to Improve Access and Affordability for Rare Disease Drugs

    Unfortunately, gaining access to care within the rare disease space can be difficult. There is often lesser education and awareness about rare conditions, less research performed, and poorer access to…

    Continue Reading China Expands Medical Insurance Coverage to Improve Access and Affordability for Rare Disease Drugs
    Paws for Emma: This Family Needs a Service Dog for Daughter with BRRS
    Source: Pixabay

    Paws for Emma: This Family Needs a Service Dog for Daughter with BRRS

    Soon after Emma Young was born, she was diagnosed with a rare genetic disorder called Bannayan-Riley-Ruvalcaba syndrome (BRRS). At two months old, she battled COVID-19. Then she was diagnosed with…

    Continue Reading Paws for Emma: This Family Needs a Service Dog for Daughter with BRRS
    Study Results Available on Dexpramipexole for Eosinophilic Asthma
    source: shutterstock.com

    Study Results Available on Dexpramipexole for Eosinophilic Asthma

      The Phase 2 EXHALE-1 clinical trial, initiated by clinical-stage biotechnology company Areteia Therapeutics, Inc. ("Areteia"), sought to understand how safe, effective, and well-tolerated dexpramipexole was in reducing symptoms of…

    Continue Reading Study Results Available on Dexpramipexole for Eosinophilic Asthma
    OI Has Led to More Than 82 Broken Bones for This 6-Year-Old
    Chronic osteomyelitis in the clavicle. Sourced from: Shannonpercivalsmith / CC BY (https://creativecommons.org/licenses/by/3.0)

    OI Has Led to More Than 82 Broken Bones for This 6-Year-Old

    For many people, a broken bone would severely interrupt their life. But six-year-old Avery Balcazar has learned to live with it—even when it’s tough. As reported by CBC News, Balcazar…

    Continue Reading OI Has Led to More Than 82 Broken Bones for This 6-Year-Old
    Rare Community Profiles: Fiercely Advocating for the SMA Community: Why Amanda Will Never Stop Fighting for her Son Kayden
    Photo courtesy of Amanda Chaffin

    Rare Community Profiles: Fiercely Advocating for the SMA Community: Why Amanda Will Never Stop Fighting for her Son Kayden

    Rare Community Profiles     Rare Community Profiles is a new Patient Worthy article series of long-form interviews featuring various stakeholders in the rare disease community, such as patients, their…

    Continue Reading Rare Community Profiles: Fiercely Advocating for the SMA Community: Why Amanda Will Never Stop Fighting for her Son Kayden

    CB-010 Shows Promise for B-Cell Non-Hodgkin Lymphoma, Study Shows

    Recent results are available from the dose escalation portion of the Phase 1 ANTLER study. In reporting from Targeted Oncology, Jordyn Sava shares that the study included 16 participants living…

    Continue Reading CB-010 Shows Promise for B-Cell Non-Hodgkin Lymphoma, Study Shows
    Mavorixafor is Safe and Effective for Treating WHIM Syndrome, Trial Data Suggests
    JerzyGorecki / Pixabay

    Mavorixafor is Safe and Effective for Treating WHIM Syndrome, Trial Data Suggests

      In the past, treatment for WHIM syndrome has focused on symptom management: treating infections and myelokathexis with antibiotics or granulocyte colony stimulating factor. Infusion can treat hypogammaglobulinemia and surgery…

    Continue Reading Mavorixafor is Safe and Effective for Treating WHIM Syndrome, Trial Data Suggests